PTC Therapeutics
PTCT
#2687
Rank
C$8.56 B
Marketcap
C$106.73
Share price
-0.76%
Change (1 day)
57.27%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2025 (TTM): C$1.07 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are C$1.77 Billion. In 2024 the company made an earning of -C$0.51 Billion, an increase over its 2023 earnings that were of -C$0.97 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$1.07 B-313.97%
2024 -C$0.51 Billion-47.84%
2023 -C$0.97 Billion18.49%
2022 -C$0.82 Billion13.34%
2021 -C$0.72 Billion28.64%
2020 -C$0.56 Billion67.94%
2019 -C$0.34 Billion87.28%
2018 -C$0.18 Billion64.95%
2017 -C$0.11 Billion-45.13%
2016 -C$0.2 Billion-16.72%
2015 -C$0.24 Billion72.64%
2014 -C$0.14 Billion90.89%
2013 -C$71.25 Million96.58%
2012 -C$36.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vertex Pharmaceuticals
VRTX
C$6.16 B 502.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$0.35 Billion-134.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-C$0.23 Billion-121.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-C$0.76 Billion-174.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-C$0.2 Billion-118.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.68 B 2,115.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland